Literature DB >> 10473327

Mother-infant interaction in post-partum women with schizophrenia and affective disorders.

D Riordan1, L Appleby, B Faragher.   

Abstract

BACKGROUND: Psychiatric mother and baby units are increasingly asked to assess parenting in people with severe mental illness, particularly schizophrenia, but little research evidence exists on which to base assessments.
METHOD: Mother-infant interaction was assessed in 26 women who had recovered from the acute phase of severe post-partum mental disorder, a validated rating scale based on direct observation was used.
RESULTS: Women with schizophrenia showed greater interaction deficits than those with affective disorders, being more remote, insensitive, intrusive and self-absorbed. The 4-month-old infants of women with schizophrenia were more avoidant, and the overall quality of mother-infant interaction in schizophrenia was poorer.
CONCLUSION: The long-term significance of these preliminary findings is not known but they raise concerns about the parenting capacity of women with schizophrenia and suggest the need for an intervention to improve parenting skills in this group.

Entities:  

Mesh:

Year:  1999        PMID: 10473327     DOI: 10.1017/s0033291798007727

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  21 in total

1.  A video ethnography approach for linking naturalistic behaviors to research constructs of neurocognition in schizophrenia.

Authors:  Elizabeth Bromley; Gail Fox Adams; John S Brekke
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

2.  Safety of antipsychotic drugs for pregnant and breastfeeding women with non-affective psychosis.

Authors:  Louise Howard; Roger Webb; Kathryn Abel
Journal:  BMJ       Date:  2004-10-23

3.  Home Visiting and Antenatal Depression Affect the Quality of Mother and Child Interactions in South Africa.

Authors:  Joan Christodoulou; Mary Jane Rotheram-Borus; Alexandra K Bradley; Mark Tomlinson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-03-26       Impact factor: 8.829

4.  Predictors of infant foster care in cases of maternal psychiatric disorders.

Authors:  Nine M-C Glangeaud-Freudenthal; Anne-Laure Sutter-Dallay; Anne-Claire Thieulin; Véronique Dagens; Marie-Agathe Zimmermann; Alain Debourg; Corinne Amzallag; Odile Cazas; Rafaële Cammas; Marie-Emmanuelle Klopfert; Christine Rainelli; Pascale Tielemans; Claudine Mertens; Michel Maron; Sylvie Nezelof; François Poinso
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-06-16       Impact factor: 4.328

5.  A cross-sectional study to investigate current social adjustment of offspring of patients with schizophrenia.

Authors:  Angela Cristina Cesar Terzian; Sérgio Baxter Andreoli; Lygia Merini de Oliveira; Jair de Jesus Mari; John McGrath
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-06       Impact factor: 5.270

6.  Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats.

Authors:  Ming Li; Radek Budin; Alison S Fleming; Shitij Kapur
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

7.  Sedation and disruption of maternal motivation underlie the disruptive effects of antipsychotic treatment on rat maternal behavior.

Authors:  Changjiu Zhao; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2008-11-17       Impact factor: 3.533

Review 8.  Antipsychotic drugs on maternal behavior in rats.

Authors:  Ming Li
Journal:  Behav Pharmacol       Date:  2015-09       Impact factor: 2.293

9.  The Role of Parent Psychopathology in Emotion Socialization.

Authors:  Rosanna P Breaux; Elizabeth A Harvey; Claudia I Lugo-Candelas
Journal:  J Abnorm Child Psychol       Date:  2016-05

10.  Transient downregulation of Dab1 protein levels during development leads to behavioral and structural deficits: relevance for psychiatric disorders.

Authors:  Catia M Teixeira; Nuria Masachs; Ashraf Muhaisen; Carles Bosch; Javier Pérez-Martínez; Brian Howell; Eduardo Soriano
Journal:  Neuropsychopharmacology       Date:  2013-09-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.